[go: up one dir, main page]

JPS6361929B2 - - Google Patents

Info

Publication number
JPS6361929B2
JPS6361929B2 JP55162621A JP16262180A JPS6361929B2 JP S6361929 B2 JPS6361929 B2 JP S6361929B2 JP 55162621 A JP55162621 A JP 55162621A JP 16262180 A JP16262180 A JP 16262180A JP S6361929 B2 JPS6361929 B2 JP S6361929B2
Authority
JP
Japan
Prior art keywords
ascofuranone
mice
days
administered
intraperitoneally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55162621A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5788119A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP55162621A priority Critical patent/JPS5788119A/ja
Publication of JPS5788119A publication Critical patent/JPS5788119A/ja
Publication of JPS6361929B2 publication Critical patent/JPS6361929B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP55162621A 1980-11-20 1980-11-20 Antitumor agent Granted JPS5788119A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55162621A JPS5788119A (en) 1980-11-20 1980-11-20 Antitumor agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55162621A JPS5788119A (en) 1980-11-20 1980-11-20 Antitumor agent

Publications (2)

Publication Number Publication Date
JPS5788119A JPS5788119A (en) 1982-06-01
JPS6361929B2 true JPS6361929B2 (nl) 1988-11-30

Family

ID=15758082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55162621A Granted JPS5788119A (en) 1980-11-20 1980-11-20 Antitumor agent

Country Status (1)

Country Link
JP (1) JPS5788119A (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005112755A (ja) * 2003-10-06 2005-04-28 Arigen Inc フェノール系誘導体を有効成分とするクリプトスポリジウム症の予防・治療剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240129695A (ko) * 2023-02-21 2024-08-28 대구가톨릭대학교산학협력단 아스코푸라논을 유효성분으로 포함하는 암 치료용 약학적 조성물

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005112755A (ja) * 2003-10-06 2005-04-28 Arigen Inc フェノール系誘導体を有効成分とするクリプトスポリジウム症の予防・治療剤
JP4553569B2 (ja) * 2003-10-06 2010-09-29 アリジェン製薬株式会社 フェノール系誘導体を有効成分とするクリプトスポリジウム症の予防・治療剤

Also Published As

Publication number Publication date
JPS5788119A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
US5225404A (en) Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
USRE40862E1 (en) Gossypolone for the treatment of cancer
RU2153332C2 (ru) Способ сенсибилизации раковых клеток к лизису, опосредованному клетками-киллерами
Bliznakov Effect of stimulation of the host defense system by coenzyme Q10 on dibenzpyrene-induced tumors and infection with Friend leukemia virus in mice
EP0350801B1 (en) Polyprenols and polyprenyl phosphates for the inhibition of tumour metastasis
JPS62228026A (ja) 免疫増強剤
EP0355604B1 (en) Anti-cancer activity potentiator
US6255291B1 (en) Composition and method for treating cancer and immunological disorders resulting in chronic conditions
KR950008767B1 (ko) 에브셀렌(Ebselen)의 새로운 의약적 용도
Gottschalk et al. The action of cortisone and ACTH on transplanted mouse tumors
US5096707A (en) Flavone-8-acetic acid and interleukin-2 in a method of treating certain cancers
Youn et al. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid
JPH07501534A (ja) ガンの治療のためのクレアチンホスフェート又はホスホエノールピルビン酸の使用
JPS6361929B2 (nl)
JP2020537689A (ja) Ａ−ノル−５αアンドロスタン化合物を含む白血球増多製剤およびその使用
JPH0686377B2 (ja) がん転移抑制剤
Sava et al. Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma
Algarra et al. Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue
Gresser et al. Effectiveness of Mouse Interferon α/β Compared to Single-Agent Chemotherapy in Increasing Survival Time of Mice After Intravenous Inoculation of Friend Erythroleukemial Cells
KR20210039414A (ko) 암의 치료를 위한 병용 요법
NL8401226A (nl) Farmaceutisch produkt met anti-tumorwerking; gebruik van een farmaceutisch produkt of van farmaceutische samenstellingen in een anti-tumortherapie.
RU2782931C2 (ru) Производные индол-3-карбоновой кислоты, обладающие противоопухолевой активностью
RU2211035C1 (ru) Противотуберкулезный препарат
RU2034543C1 (ru) Противоопухолевое средство
EP1854474A1 (en) Immunopotentiating agent